腦震盪市場機會、成長動力、產業趨勢分析與 2025 - 2034 年預測

2024 年全球腦震盪市場價值為 75 億美元，預計 2025 年至 2034 年期間將以 4.8% 的複合年成長率強勁成長。這一成長主要得益於創傷性腦損傷發病率的上升、人們對腦震盪管理的認知的不斷提高，以及支持診斷和治療解決方案進步的監管政策。

從細分市場來看，腦震盪市場分為評估和診斷工具以及治療解決方案。評估和診斷工具部分是 2024 年的主導類別，創收 53 億美元。該領域的主導地位可歸因於診斷技術的快速進步，包括磁振造影（MRI）和電腦斷層掃描（CT），這些技術顯著提高了腦震盪診斷的準確性。此外，功能性神經成像和擴散張量成像 (DTI) 等創新正在突破診斷能力的界限，可以檢測到傳統方法可能遺漏的細微腦損傷。

市場也按最終用途進行細分，包括醫院、診斷中心和其他醫療機構。醫院是 2024 年的主要細分市場，預計到 2034 年將達到 77 億美元。包括神經科醫生、急救專家和復健專家在內的多學科醫療團隊的存在確保了全面的護理，從而帶來了更好的患者治療效果。這種綜合方法對於有效處理腦震盪病例起著至關重要的作用。

在美國，腦震盪市場在 2024 年的規模為 32 億美元，預計在整個預測期內的複合年成長率為 4.2%。美國擁有完善的醫療保健基礎設施、不斷創新的醫療技術以及嚴格的安全法規，尤其是在體育領域，這些都強調了可靠的腦震盪評估工具的必要性。這些因素導致對先進的腦震盪診斷的需求不斷成長。此外，大量的研究投入和攜帶式診斷設備的日益普及預計將進一步推動該地區市場的成長。

目錄

第 1 章：方法論與範圍

第 2 章：執行摘要

第 3 章：產業洞察

• 產業生態系統分析
• 產業衝擊力
  • 成長動力
    • 創傷性腦損傷不斷增加
    • 技術進步
    • 意識不斷增強
    • 支持性監管環境
  • 產業陷阱與挑戰
    • 先進診斷工具成本高昂
• 成長潛力分析
• 監管格局
• 報銷場景
• 技術格局
• 未來市場趨勢
• 差距分析
• 波特的分析
• PESTEL 分析

第4章：競爭格局

• 介紹
• 公司矩陣分析
• 主要市場參與者的競爭分析
• 競爭定位矩陣
• 策略儀表板

第 5 章：市場估計與預測：按類型，2021 年至 2034 年

• 主要趨勢
• 評估和診斷工具
  • CT
  • 磁振造影
  • 腦電圖
  • 其他評估和診斷工具
• 治療

第 6 章：市場估計與預測：依最終用途，2021 年至 2034 年

• 主要趨勢
• 醫院
• 診斷中心
• 其他最終用戶

第 7 章：市場估計與預測：按地區，2021 年至 2034 年

• 主要趨勢
• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 英國
  • 法國
  • 西班牙
  • 義大利
  • 荷蘭
• 亞太地區
  • 中國
  • 日本
  • 印度
  • 澳洲
  • 韓國
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
• 中東和非洲
  • 南非
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國

第8章：公司簡介

• Advanced Brain Monitoring
• BIOMÉRIEUX
• BrainScope
• Compumedics
• GE Healthcare
• Healius
• INTEGRA LIFESCIENCES
• Koninklijke Philips NV
• NanoDx
• NIHON KOHDEN
• Oculogica
• Siemens Healthineers

The Global Concussion Market was valued at USD 7.5 billion in 2024 and is expected to experience robust growth at a CAGR of 4.8% from 2025 to 2034. This growth is primarily driven by the rising incidence of traumatic brain injuries, growing awareness about concussion management, and favorable regulatory policies that support advancements in diagnostic and treatment solutions.

In terms of market segments, the concussion market is divided into assessment and diagnostic tools, as well as treatment solutions. The assessment and diagnostic tools segment was the dominant category in 2024, generating USD 5.3 billion. This segment's dominance can be attributed to the rapid advancements in diagnostic technologies, including magnetic resonance imaging (MRI) and computed tomography (CT) scans, which have significantly improved concussion diagnosis accuracy. In addition, innovations such as functional neuroimaging and diffusion tensor imaging (DTI) are pushing the boundaries of diagnostic capabilities, allowing for the detection of even subtle brain injuries that traditional methods may miss.

The market is also segmented by end-use, which includes hospitals, diagnostic centers, and other healthcare facilities. Hospitals were the leading segment in 2024 and are expected to reach USD 7.7 billion by 2034. Equipped with state-of-the-art diagnostic technologies, hospitals are the preferred choice for concussion evaluation and treatment. The presence of multidisciplinary healthcare teams, including neurologists, emergency specialists, and rehabilitation experts, ensures comprehensive care, leading to better patient outcomes. This comprehensive approach plays a vital role in managing concussion cases effectively.

In the U.S., the concussion market accounted for USD 3.2 billion in 2024 and is projected to grow at a CAGR of 4.2% throughout the forecast period. The U.S. benefits from a well-established healthcare infrastructure, continuous innovations in medical technologies, and stringent safety regulations, particularly in sports, which emphasize the need for reliable concussion assessment tools. These factors contribute to a growing demand for advanced concussion diagnostics. Additionally, substantial investments in research and the rising adoption of portable diagnostic devices are expected to further fuel market growth in the region.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates and calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360⁰ synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Rising traumatic brain injuries
    • 3.2.1.2 Technological advancements
    • 3.2.1.3 Growing awareness
    • 3.2.1.4 Supportive regulatory landscape
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 High cost of advanced diagnostics tools
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Reimbursement scenario
• 3.6 Technology landscape
• 3.7 Future market trends
• 3.8 Gap analysis
• 3.9 Porter’s analysis
• 3.10 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Competitive analysis of major market players
• 4.4 Competitive positioning matrix
• 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Type, 2021 – 2034 ($ Mn)

• 5.1 Key trends
• 5.2 Assessment and diagnostic tools
  • 5.2.1 CT
  • 5.2.2 MRI
  • 5.2.3 EEG
  • 5.2.4 Other assessment and diagnostic tools
• 5.3 Treatment

Chapter 6 Market Estimates and Forecast, By End Use, 2021 – 2034 ($ Mn)

• 6.1 Key trends
• 6.2 Hospitals
• 6.3 Diagnostic centers
• 6.4 Other end users

Chapter 7 Market Estimates and Forecast, By Region, 2021 – 2034 ($ Mn)

• 7.1 Key trends
• 7.2 North America
  • 7.2.1 U.S.
  • 7.2.2 Canada
• 7.3 Europe
  • 7.3.1 Germany
  • 7.3.2 UK
  • 7.3.3 France
  • 7.3.4 Spain
  • 7.3.5 Italy
  • 7.3.6 Netherlands
• 7.4 Asia Pacific
  • 7.4.1 China
  • 7.4.2 Japan
  • 7.4.3 India
  • 7.4.4 Australia
  • 7.4.5 South Korea
• 7.5 Latin America
  • 7.5.1 Brazil
  • 7.5.2 Mexico
  • 7.5.3 Argentina
• 7.6 Middle East and Africa
  • 7.6.1 South Africa
  • 7.6.2 Saudi Arabia
  • 7.6.3 UAE

Chapter 8 Company Profiles

• 8.1 Advanced Brain Monitoring
• 8.2 BIOMÉRIEUX
• 8.3 BrainScope
• 8.4 Compumedics
• 8.5 GE Healthcare
• 8.6 Healius
• 8.7 INTEGRA LIFESCIENCES
• 8.8 Koninklijke Philips N.V.
• 8.9 NanoDx
• 8.10 NIHON KOHDEN
• 8.11 Oculogica
• 8.12 Siemens Healthineers